Although MIF expression alone does not significantly affect overall survival, CD163 expression—on tumor-associated macrophages—has been linked to disease-free survival, suggesting that MIF influences the TME in patients with triple-negative BC (183). This evidence concerns the gene MIF and breast cancer.